MediPharm Labs (TSE:LABS) Reaches New 12-Month High – What’s Next?

MediPharm Labs Corp. (TSE:LABSGet Free Report)’s stock price hit a new 52-week high on Monday . The stock traded as high as C$0.10 and last traded at C$0.09, with a volume of 745630 shares. The stock had previously closed at C$0.09.

MediPharm Labs Price Performance

The firm has a market cap of C$37.35 million, a PE ratio of -3.10 and a beta of 0.88. The company has a debt-to-equity ratio of 1.45, a quick ratio of 3.10 and a current ratio of 3.21. The firm’s 50-day moving average price is C$0.07 and its two-hundred day moving average price is C$0.07.

MediPharm Labs Company Profile

(Get Free Report)

MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada and internationally. The company formulates, processes, packages, and distributes cannabis extracts and advanced cannabinoid-based products.

See Also

Receive News & Ratings for MediPharm Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MediPharm Labs and related companies with MarketBeat.com's FREE daily email newsletter.